No CrossRef data available.
Published online by Cambridge University Press: 14 March 2025
As the first phase of Japan's response to COVID-19 ends with reasonable success, the country now moves on to the second phase. This essay aims to explain the first phase response from three perspectives. First, how does Japan's response compare to that in Taiwan and South Korea? How and why did Japan lag behind? Second, despite not matching the success of these regional neighbors, Japan has been relatively successful. What accounts for this success? Third, we will examine several unresolved issues during this first phase such as testing capacity, drug treatment and development of a vaccine.